Zhaoke Ophthalmology Wins NMPA Approval for Cyclosporine Eye Gel

PUBT · 1d ago
Zhaoke Ophthalmology Wins NMPA Approval for Cyclosporine Eye Gel
  • Zhaoke Ophthalmology's cyclosporine ophthalmic gel received National Medical Products Administration marketing approval for dry eye disease on November 10, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhaoke Ophthalmology Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261113-12412510), on November 13, 2026, and is solely responsible for the information contained therein.